Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

NCT01743014 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Type 2
Diabetic Nephropathy
Vascular Disease

Interventions

DRUG: Ramipril
DRUG: Clopidogrel

Sponsor

AHEPA University Hospital

Collaborators

[object Object]